Damae Medical Revenue and Competitors
Estimated Revenue & Valuation
- Damae Medical's estimated annual revenue is currently $10M per year.
- Damae Medical's estimated revenue per employee is $251,000
Employee Data
- Damae Medical has 40 Employees.
- Damae Medical grew their employee count by 8% last year.
Damae Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Clinical Director | Reveal Email/Phone |
2 | Ingénieur recherche et développement Optics | Reveal Email/Phone |
3 | Project Leader - Computer Vision & Image Quality | Reveal Email/Phone |
Damae Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $31.6M | 126 | 9% | N/A | N/A |
#2 | $65.8M | 262 | 3% | N/A | N/A |
#3 | $55.7M | 222 | 47% | N/A | N/A |
#4 | $43.4M | 173 | -9% | N/A | N/A |
#5 | $32.4M | 129 | 5% | N/A | N/A |
#6 | $115M | 458 | 9% | N/A | N/A |
#7 | $36.4M | 145 | 9% | N/A | N/A |
#8 | $143.7M | 409 | -11% | €83.1M | N/A |
#9 | $32.4M | 129 | 2% | N/A | N/A |
#10 | $2571.2M | 10244 | 4% | N/A | N/A |
What Is Damae Medical?
DAMAE Medical is a French innovative start-up founded in 2014 by two engineers and a researcher from the French's National Centre for Scientific Research. DAMAE Medical develops deepLive™ medical device, the new best-in-class imaging system pairing penetration and cellular resolution in 3D. deepLive™ integrates LC-OCT (Line-field Confocal Optical Coherence Tomography) technology which provides a unique 3D imaging modality, allowing the user to switch from a histology-like vertical mode to a confocal-like horizontal mode, and to record a 3D stack of tissue volumes in situ.   This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with the surface of the skin. Indeed, the technology developed by DAMAE Medical gives clinicians further information than the usual dermoscopic examination. In cases where the abnormality is a tumor, the dermatologist will quickly determine the treatment to use and then immediately remove it by perfectly respecting the surgical margins. On the contrary, if the tissue is healthy, monitoring will be carried out but no biopsies will take place. deepLive™ is adapted to the imaging of multiple skin conditions, promoting efficient, reassuring and non-invasive patient management. For more information, please contact us by email: info@damae-medical.com
keywords:N/AN/A
Total Funding
40
Number of Employees
$10M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Damae Medical News
Researchers at the Institute of Optics at Université Paris-Saclay and DAMAE Medical, both in Paris, and a clinician at St. Etienne...
Damae Medical, a medtech company developing optical imaging medical devices and AI software platform to help dermatologists manage their...
PARIS Damae Medical SAS has just raised nearly $6 million to develop new technology to detect skin cancer noninvasively without need for a...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.6M | 40 | -18% | N/A |
#2 | $4.6M | 40 | -22% | N/A |
#3 | $4.8M | 40 | -11% | N/A |
#4 | $4.5M | 40 | N/A | N/A |
#5 | $4.6M | 40 | N/A | N/A |